Amiloride kills malignant glioma cells independent of its inhibition of the sodium-hydrogen exchanger

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 1, 2004, Pages 67-74

  Hegde, Manu ^a   Roscoe, Jane ^a   Cala, Peter ^a   Gorin, Fredric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DICHLOROBENZAMIL; AMILORIDE; AMILORIDE DERIVATIVE; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLPHENYLALANYLALANYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CARIPORIDE; CASPASE 3; CASPASE INHIBITOR; SODIUM PROTON EXCHANGE PROTEIN; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CYCLE; CELL PH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENZYME ACTIVATION; GLIOMA CELL; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RAT;

AMILORIDE; ANIMALS; ASTROCYTES; CASPASES; CELL DIVISION; CELL SURVIVAL; ENZYME ACTIVATION; GLIOMA; HUMANS; HYDROGEN-ION CONCENTRATION; RATS; SODIUM-CALCIUM EXCHANGER; SODIUM-HYDROGEN ANTIPORTER; TUMOR CELLS, CULTURED;

EID: 3042552860     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.065029     Document Type: Article

References (42)

1. Allen DG and Xiao XH (2003) Role of the cardiac Na+/H+ exchanger during ischemia and reperfusion. Cardiovasc Res 57:934-941.
2. 3 cotransport. J Gen Physiol 110:467-483.
3. 3. J Gen Physiol 110:453-465.
4. Bischof G, Cosentini E, Hamilton G, Riegler M, Zacherl J, Teleky B, Feil W, Schiessel R, Machen TE, and Wenzl E (1996) Effects of extracellular pH on intracellular pH-regulation and growth in a human colon carcinoma cell-line. Biochim Biophys Acta 1282:131-139.
5. Boyarsky G, Ganz M, Sterzel RB, and Boron W (1988) pH regulation in single glomerular mesagial cells. I. Acid extrusion in absence and presence of HCO3. Am J Physiol 255:C844-C856.
6. Boyarsky G, Ransom B, Schlue WR, Davis MB, and Boron WF (1993) Intracellular pH regulation in single cultured astrocytes from rat forebrain. Glia 8:241-248.
7. Boyer MJ and Tannock IF (1992) Regulation of intracellular pH in tumor cell lines: influence of microenvironmental conditions. Cancer Res 52:4441-4447.
8. Brandes AA, Vastola F, and Monfardini S (1999) Reoperation in recurrent high-grade gliomas: literature review of prognostic factors and outcome. Am J Clin Oncol 22:387-390.
9. Dailey ME and Waite M (1999) Confocal imaging of microglial cell dynamics in hippocampal slice cultures. Methods 18:222-230.
10. Frelin C, Barbry P, Vigne P, Chassande O, Cragoe EJ Jr, and Lazdunski M (1988) Amiloride and its analogs as tools to inhibit Na+ transport via the Na+ channel, the Na+/H+ antiport and the Na+/Ca2+ exchanger. Biochimie 70:1285-1290.
11. García-Cañero R, Trilla C, Pérez de Diego J, Diaz-Gil JJ, and Cobo JM (1999) Na+:H+ exchange inhibition induces intracellular acidosis and differentially impairs cell growth and viability of human and rat hepatocarcinoma cells. Toxicol Lett 106:215-228.
12. Glunde K, Dussmann H, Juretschke HP, and Leibfritz D (2002) Na(+)/H(+) exchange subtype 1 inhibition during extracellular acidification and hypoxia in glioma cells. J Neurochem 80:36-44.
13. Hasuda K, Lee C, and Tannock IF (1994) Antitumor activity of nigericin and 5-(N-ethyl-N-isopropyl)amiloride - an approach to therapy based on cellular acidification and the inhibition of regulation of intracellular pH. Oncol Res 6:259-268.
14. Hertz L, Juurlink BHJ, Hertz E, Fosmark H, and Schousboe A (1989) Preparation of primary cultures of mouse (rat) astrocytes., in A dissection and Tissue Culture Manual of the Nervous System (Shahar VA, Vernadakis A and Haber B eds) pp 105-108, Wiley-Liss, New York.
15. Hirt UA, Gantner F, and Leist M (2000) Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms. J Immunol 164:6520-6529.
16. - exchange. Eur J Cancer 29A:132-137.
17. Hubesch B, Sappeymarinier D, Roth K, Meyerhoff DJ, Matson GB, and Weiner MW (1990) P-31 MR spectroscopy of normal human brain and brain tumors. Radiology 174:401-409.
18. Iwamoto T, Kita S, and Shigekawa M (2002) [Functional analysis of Na+/Ca2+ exchanger using novel drugs and genetically engineered mice]. Nippon Yakurigaku Zasshi 120:91P-93P.
19. Jankun J and Skrzypczak-Jankun E (1999) Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride. Cancer Biochem Biophys 17:109-123.
20. Katabi MM, Chan HL, Karp SE, and Batist G (1999) Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells. Hum Gene Ther 10:155-164.
21. Kimura J, Watanabe Y, Li L, and Watano T (2002) Pharmacology of Na+/Ca2+ exchanger. Ann NY Acad Sci 976:513-519.
22. Kleyman TR and Cragoe EJ Jr (1988) Amiloride and its analogs as tools in the study of ion transport. J Membr Biol 105:1-21.
23. Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, and Linet MS (1999) Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91:1382-1390.
24. Majno G and Joris I (1995) Apoptosis, oncosis and necrosis. An overview of cell death. Am J Pathol 146:3-15.
25. Masereel B, Pochet L, and Laeckmann D (2003) An overview of inhibitors of Na(+)/H(+) exchanger. Eur J Med Chem 6:547-554.
26. McLean LA, Roscoe J, Jorgensen NK, Gorin FA, and Cala PM (2000) Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes. Am J Physiol 278:C676-C688.
27. Miccoli L, Oudard S, Sureau F, Porison F, Dutrillaux B, and Poupon MF (1996) Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line. Biochem J 313:957-962.
28. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
29. Musgrove E, Seaman M, and Hedley D (1987) Relationship between cytoplasmic pH and proliferation during exponential growth and cellular quiescence. Exp Cell Res 172:65-75.
30. Narita Y, Asai A, Kuchino Y, and Kirino T (2000) Actinomycin D and staurosporine, potent apoptosis inducers in vitro, are potentially effective chemotherapeutic agents against glioblastoma multiforme. Cancer Chemother Pharmacol 45:149-156.
31. Neumar RW, Meng FH, Mills AM, Xu YA, Zhang C, Welsh FS, and Siman R (2001) Calpain activity in the rat brain after transient forebrain ischemia. Exp Neurol 170:27-35.
32. Nguyen EV, Hegde M, and Gorin FA (2002) Inhibition of NHE1 causes delayed cell death in U118 gliomas. J Investig Med 50:429.
33. Ramirez MA, Toriano R, Parisi M, and Malnic G (2000) Control of cell pH in the T84 colon cell line. J Membr Biol 177:149-157.
34. Reichert M, Steinbach JP, Supra P, and Weller M (2002) Modulation of growth and radiochemosensitivity of human malignant glioma cells by acidosis - a new look at the efficacy of nitrosoureas. Cancer 95:1113-1119.
35. Reuter H, Henderson SA, Han T, Matsuda T, Baba A, Ross RS, Goldhaber JI, and Philipson KD (2002) Knockout mice for pharmacological screening: testing the specificity of Na+-Ca2+ exchange inhibitors. Circ Res 91:90-92.
36. Rotin D, Steele-Norwood D, Grinstein S, and Tannock I (1989) Requirement of the Na+/H+ exchanger for tumor growth. Cancer Res 49:205-211.
37. Rutter A, Hugenholtz H, Saunders JK, and Smith ICP (1995) One-dimensional phosphorus-31 chemical shift imaging of human brain tumors. Investig Radiol 30:359-366.
38. Schiffer D, Fiano V, Chiado-Piat L, Mortara P, Richiardi P, and Cavalla P (2001) Distribution of activated caspase-3 in relation with apoptosis in human malignant gliomas. Neurosci Lett 300:37-40.
39. Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011-1018.
40. Szolgay-Daniel E, Carlsson J, Zierold K, Holtermann G, Dufau E, and Acker H (1991) Effects of amiloride treatment on U-118 MG and U-251 MG human glioma and HT-29 human colon carcinoma cells. Cancer Res 51:1039-1044.
41. Viviani B, Corsini E, Galli CL, Padovani A, Ciusani E, and Marinovich M (2000) Dying neural cells activate glia through the release of a protease product. Glia 32:84-90.
42. Wong P, Kleemann HW, and Tannock IF (2002) Cytostatic potential of novel agents that inhibit the regulation of intracellular pH. Br J Cancer 87:238-245.